Anacor to Detail Chemistry Behind Lead Compounds
Complete the form below to unlock access to ALL audio articles.
Anacor Pharmaceuticals has announced it has made two presentations at the American Chemical Society National Meeting & Exposition this week in San Francisco.
Researchers have made an oral presentation on the chemistry and discovery of AN2690, Anacor's topical antifungal drug candidate being developed for onychomycosis, a fungal infection of the toenail and nail bed, as well as a poster presentation on the discovery of AN0128, Anacor's treatment for atopic dermatitis.
The conference is being held at the Moscone Center.
AN0128 Poster Presentation:
MEDI 332
Discovery and SAR of diphenylborinic acid picolinate esters as a potent antibacterial and anti-inflammatory agent for the treatment of skin diseases
General Poster Session : 7 to 9 p.m., Wednesday, Sept. 13, Moscone Center - Hall D
AN2690 Oral Presentation:
MEDI 296
Discovery and SAR of a boron-containing clinical molecule (AN-2690) for topical onychomycosis treatment
General Oral Session : 1:30 to 4:50 p.m., Tuesday, Sept. 12, Moscone Center - Room 103
